Delivery Order SPE2DB24D6039-SPE2DB24FLEBE
Award Date
9/23/24
Potential Completion Date
9/24/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,797.80 firm fixed-price contract is for the delivery of butalbital-aspirin-caffeine medication. The contract has an ultimate completion date of January 9, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,061.27, is for the delivery of 4,568,139,083 units of the pharmaceutical product Butalbital-Aspirin-Caffeine Capsules. The contract has an ultimate completion date of May 6, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,228.50, is for the delivery of BUTALB-ACETAMIN-CAFF 50-325-40 100S, a pharmaceutical product, to be completed by May 1, 2025. The contract is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The order, valued at $1,306.84, is for the supply of BUTALB-ACETAMIN-CAFF 50-300-40 100S pharmaceutical products. The contract has a period of performance through August 28, 2024 and is a firm fixed-price arrangement. Amerisourcebergen, a major pharmaceutical distributor, has been...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of BUTALB-ACETAMIN-CAF-COD 50-300 medication. The $1,639.43 firm fixed price contract has a completion date of September 19, 2024. The award is not associated with a set-aside program. Amerisourcebergen holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to provide a...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide BUTALB-ACETAMIN-CAFF 50-325-40 500S medications. The contract has a ceiling value of $1,350.74 and an ultimate completion date of July 9, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which allows...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BUTALBITAL ACETAMINOP, a medication, with a ceiling value of $2,558.85 and a period of performance through June 13, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,198.96 firm fixed-price delivery order is for the supply of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of October 2, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,034.12, is a delivery order from the Defense Logistics Agency (DLA), a defense agency, for the supply of a specific pharmaceutical product - BUTALB-ACETAMIN-CAFF 50-300-40 100S. The contract is for a firm fixed price and has an ultimate completion date of June 9, 2025. The award is not set aside and is open to full and open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BUTALB-ACETAMIN-CAFF 50-325-40 100S, a pharmaceutical product, with a ceiling value of $1,285.49 and a period of performance ending on May 13, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....